BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27366060)

  • 1. Factors associated with exacerbation in mild- to-moderate COPD patients.
    Kim JK; Lee SH; Lee BH; Lee CY; Kim do J; Min KH; Kim SK; Yoo KH; Jung KS; Hwang YI
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1327-33. PubMed ID: 27366060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.
    Lee H; Jhun BW; Cho J; Yoo KH; Lee JH; Kim DK; Lee JD; Jung KS; Lee JY; Park HY
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3301-3310. PubMed ID: 29180860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
    Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe COPD cases from Korea, Poland, and USA have substantial differences in respiratory symptoms and other respiratory illnesses.
    Kim WJ; Yim JJ; Kim DK; Lee MG; Fuhlbrigge AL; Sliwinski P; Hawrylkiewicz I; Wan ES; Cho MH; Silverman EK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3415-3423. PubMed ID: 29238186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.
    Jeong SH; Lee H; Carriere KC; Shin SH; Moon SM; Jeong BH; Koh WJ; Park HY
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1857-65. PubMed ID: 27536097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified Medical Research Council scale vs Baseline Dyspnea Index to evaluate dyspnea in chronic obstructive pulmonary disease.
    Perez T; Burgel PR; Paillasseur JL; Caillaud D; Deslée G; Chanez P; Roche N;
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1663-72. PubMed ID: 26316740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation.
    Jo YS; Yoon HI; Kim DK; Yoo CG; Lee CH
    Int J Chron Obstruct Pulmon Dis; 2018; 13():101-107. PubMed ID: 29317814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan.
    Lin CW; Chen YY; Chen YJ; Liang CY; Lin MS; Chen W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1493-500. PubMed ID: 26251589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Frequency of Chronic Obstructive Pulmonary Disease Exacerbations in Korean Patients: Findings From the KOCOSS Cohort 2012-2021.
    Rhee CK; Choi JY; Park YB; Yoo KH
    J Korean Med Sci; 2024 May; 39(19):e164. PubMed ID: 38769923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation-related impairment of quality of life and work productivity in severe and very severe chronic obstructive pulmonary disease.
    Solem CT; Sun SX; Sudharshan L; Macahilig C; Katyal M; Gao X
    Int J Chron Obstruct Pulmon Dis; 2013; 8():641-52. PubMed ID: 24376348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.
    van Geffen WH; Tan DJ; Walters JA; Walters EH
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD011600. PubMed ID: 38054551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of once-daily glycopyrronium in predominantly Chinese patients with moderate-to-severe chronic obstructive pulmonary disease: the GLOW7 study.
    Wang C; Sun T; Huang Y; Humphries M; Bai L; Li L; Wang Q; Kho P; Firth R; D'Andrea P
    Int J Chron Obstruct Pulmon Dis; 2015; 10():57-68. PubMed ID: 25609940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).
    Yang T; Cai B; Cao B; Kang J; Wen F; Chen Y; Jian W; Wang C
    Ther Adv Respir Dis; 2023; 17():17534666231167353. PubMed ID: 37073797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluticasone propionate/formoterol for COPD management: a randomized controlled trial.
    Papi A; Dokic D; Tzimas W; Mészáros I; Olech-Cudzik A; Koroknai Z; McAulay K; Mersmann S; Dalvi PS; Overend T
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1961-1971. PubMed ID: 28740376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of subtypes in subjects with mild-to-moderate airflow limitation and its clinical and socioeconomic implications.
    Lee JH; Rhee CK; Kim K; Kim JA; Kim SH; Yoo KH; Kim WJ; Park YB; Park HY; Jung KS
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1135-1144. PubMed ID: 28442900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.